Dimensional Fund Advisors LP Buys New Position in Cantel Medical Corp. (CMD)

Dimensional Fund Advisors LP acquired a new position in Cantel Medical Corp. (NYSE:CMD) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 972,355 shares of the company’s stock, valued at approximately $75,756,000. Dimensional Fund Advisors LP owned about 2.34% of Cantel Medical Corp. as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Principal Financial Group Inc. bought a new stake in shares of Cantel Medical Corp. during the 2nd quarter valued at $21,919,000. Rhumbline Advisers bought a new stake in shares of Cantel Medical Corp. during the 2nd quarter valued at $5,892,000. Bank of New York Mellon Corp bought a new stake in shares of Cantel Medical Corp. during the 2nd quarter valued at $38,718,000. Kennedy Capital Management Inc. bought a new stake in shares of Cantel Medical Corp. during the 2nd quarter valued at $6,666,000. Finally, Legal & General Group Plc purchased a new position in shares of Cantel Medical Corp. during the 2nd quarter valued at $5,439,000. 83.83% of the stock is owned by institutional investors and hedge funds.

CMD has been the topic of a number of analyst reports. Sidoti upgraded shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 target price on the stock in a research note on Wednesday, August 2nd. Zacks Investment Research upgraded shares of Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a research note on Tuesday, August 1st. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cantel Medical Corp. in a research note on Friday, September 1st. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $91.67.

In other Cantel Medical Corp. news, Director Mark N. Diker sold 7,000 shares of the stock in a transaction that occurred on Tuesday, October 3rd. The shares were sold at an average price of $98.90, for a total value of $692,300.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director George L. Fotiades sold 6,000 shares of the firm’s stock in a transaction that occurred on Friday, October 13th. The stock was sold at an average price of $95.23, for a total transaction of $571,380.00. The disclosure for this sale can be found here. Insiders sold 33,500 shares of company stock valued at $3,296,255 in the last ninety days. 14.90% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by BBNS and is owned by of BBNS. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://baseballnewssource.com/markets/dimensional-fund-advisors-lp-takes-75-76-million-position-in-cantel-medical-corp-cmd/1701225.html.

Cantel Medical Corp. (NYSE:CMD) opened at 95.42 on Wednesday. The company’s 50-day moving average is $87.86 and its 200 day moving average is $78.49. Cantel Medical Corp. has a one year low of $68.19 and a one year high of $99.83. The company has a market capitalization of $3.96 billion, a P/E ratio of 55.80 and a beta of 1.25.

Cantel Medical Corp. (NYSE:CMD) last announced its quarterly earnings data on Thursday, September 28th. The company reported $0.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.02. Cantel Medical Corp. had a net margin of 9.27% and a return on equity of 17.60%. The business had revenue of $205.50 million for the quarter, compared to analyst estimates of $200.32 million. Cantel Medical Corp.’s revenue was up 14.8% on a year-over-year basis. On average, equities analysts anticipate that Cantel Medical Corp. will post $2.34 earnings per share for the current year.

Cantel Medical Corp. Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Institutional Ownership by Quarter for Cantel Medical Corp. (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.